JENNIFER MAY: Open Payments
NPI 1962992958 · LUDINGTON, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,330 in 51 payments from 23 companies in 2025. Trend: 2023 $142 · 2024 $1,321 · 2025 $1,330
Food & beverage: $1,109Education: $221
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $189 |
| Astellas Pharma US Inc | 4 | $167 |
| Merck Sharp & Dohme LLC | 6 | $139 |
| Janssen Biotech, Inc. | 5 | $108 |
| Novartis Pharmaceuticals Corporation | 3 | $85 |
| Incyte Corporation | 3 | $75 |
| E.R. Squibb & Sons, L.L.C. | 3 | $71 |
| Celgene Corporation | 2 | $58 |
| PFIZER INC. | 3 | $53 |
| GENZYME CORPORATION | 3 | $52 |
Products named: KEYTRUDA, OPDIVO, JAKAFI, RYBREVANT, Fabhalta, SARCLISA, Padcev, XPOVIO.
Industry payments across MI — which companies pay providers there.
